• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Luteolin

Luteolin

Product ID L8377
Cas No. 491-70-3
Purity ≥95%
Product Unit SizeCostQuantityStock
100 mg $139.00 In stock
500 mg $433.90 In stock
1 g $607.70 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Luteolin is a flavonoid found in various plant sources. Luteolin exhibits antioxidative, anti-inflammatory, neuromodulatory, anti-diabetic, antihypertensive, and anticancer chemotherapeutic activities. In vitro and in vivo, luteolin inhibits LPS-induced expression of IL-6 by inhibiting JNK phosphorylation and decreasing the binding of AP-1 transcription factor to the IL-6 promoter. In animal models of experimental autoimmune encephalitis (EAE), luteolin inhibits mast cell activity and mast cell-dependent T cell activation, lessening disease pathology. Luteolin inhibits phosphodiesterases (PDE 1-5) and may also inhibit α2-adrenergic receptors as it reverses xylazine/ketamine-induced anesthesia in vivo. Luteolin also increases monoamine transport, potentially through potentiation of DAT and NET. In diabetic mice, luteolin decreases mast cell and macrophage infiltration, expression of inflammatory cytokines, glucose tolerance, insulin sensitivity, and apoptosis. Luteolin decreases systolic blood pressure in spontaneously hypertensive rats and decreases expression of MMP9 and VEGF, suppressing tumor growth in animal models with gastric cancer xenografts. Additionally, luteolin inhibits heat shock protein 90 (HSP90) and IGF-1R.

Product Info

Cas No.

491-70-3

Purity

≥95%

Formula

C15H10O6

Formula Wt.

286.24

Chemical Name

2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-1- benzopyran-4-one

IUPAC Name

2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one

Synonym

3',4',5,7-Tetrahydroxyflavone, Digitoflavone, Cyanidenon

Melting Point

~330°C (lit.)

Solubility

Soluble in methanol and alkaline solutions. Slightly soluble in water. DMSO to 57 mg/mL, Ethanol to 6mg/mL

Appearance

A yellow crystalline powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

L8377 MSDS PDF

Info Sheet

L8377 Info Sheet PDF

References

Xu N, Zhang L, Dong J, et al. Low-dose diet supplement of a natural flavonoid, luteolin, ameliorates diet-induced obesity and insulin resistance in mice. Mol Nutr Food Res. 2014 Jun;58(6):1258-68. PMID: 24668788.

Chen D, Bi A, Dong X, et al. Luteolin exhibits anti-inflammatory effects by blocking the activity of heat shock protein 90 in macrophages. Biochem Biophys Res Commun. 2014 Jan 3;443(1):326-32. PMID: 24321097.

Lv GY, Zhang YP, Gao JL, et al. Combined antihypertensive effect of luteolin and buddleoside enriched extracts in spontaneously hypertensive rats. J Ethnopharmacol. 2013 Nov 25;150(2):507-13. PMID: 24080032.

Yang Y, Shen J, Yu X, et al. Identification of an inhibitory mechanism of luteolin on the insulin-like growth factor-1 ligand-receptor interaction. Chembiochem. 2013 May 27;14(8):929-33. PMID: 23630137.

Lu XY, Li YH, Xiao XW, et al. Inhibitory effects of luteolin on human gastric carcinoma xenografts in nude mice and its mechanism. Zhonghua Yi Xue Za Zhi. 2013 Jan 8;93(2):142-6. PMID: 23648354.

Yu MC, Chen JH, Lai CY, et al. Luteolin, a non-selective competitive inhibitor of phosphodiesterases 1-5, displaced [3H]-rolipram from high-affinity rolipram binding sites and reversed xylazine/ketamine-induced anesthesia. Eur J Pharmacol. 2010 Feb 10;627(1-3):269-75. PMID: 19853596.

Zhao G, Qin GW, Wang J, et al. Functional activation of monoamine transporters by luteolin and apigenin isolated from the fruit of Perilla frutescens (L.) Britt. Neurochem Int. 2010 Jan;56(1):168-76. PMID: 19815045.

Theoharides TC. Luteolin as a therapeutic option for multiple sclerosis. J Neuroinflammation. 2009 Oct 13;6:29. PMID: 19825165.

Jang S, Kelley KW, Johnson RW. Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci U S A. 2008 May 27;105(21):7534-9. PMID: 18490655.

Kang KP, Park SK, Kim DH, et al. Luteolin ameliorates cisplatin-induced acute kidney injury in mice by regulation of p53-dependent renal tubular apoptosis. Nephrol Dial Transplant. 2011 Mar;26(3):814-822. PMID: 20817674.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • I058584

    Ibotenic Acid

    Analog of glutamate

    ≥98%
  • P2012

    PF-04217903

    Triazolopyrazine; c-MET inhibitor.

    ≥98%
  • C0396

    CAY10505

    p110γ PI3K inhibitor.

    ≥98%
  • D0375

    Dasatinib Monohydrate

    Abl, PDGFR, EphR, Src, k-Kit, FYN, LCK, HCK inh...

    ≥98%
  • L5767

    Loratadine

    Histamine H1 antagonist, FIASMA.

    ≥98%
  • C9881

    Cytochalasin D

    Mycotoxin produced by Aspergillus; actin polyme...

    ≥98%
  • A9978

    Aztreonam

    β-lactam; penicillin binding protein inhibitor...

    ≥96%
  • P6818

    Prednisolone

    Cortisol derivative; glucocorticoid agonist.

    ≥98%
  • G5216

    GNE-7915

    LRRK2 inhibitor.

    ≥98%
  • B8073

    4-tert-Butyl-5-Methoxycatechol

    BHA derivative.

    ≥98%
  • V3444

    Vilazodone

    5-HT1A partial agonist, SERT inhibitor.

    ≥98%
  • R0348

    Ramelteon

    Melatonin analog; MT1/2 agonist.

    ≥99%
  • R2816

    Recombinant HIV-2 gp36

    Recombinant HIV-1 glycoprotein antigen fragment...

    ≥95%
  • P9870

    Pyridostatin Hydrochloride

    G-quadruplex ligand; DNA breakage inducer.

    ≥97%
  • A0816

    Acemetacin

    Glycolic acid ester prodrug of indomethacin, NS...

    ≥98%
  • L960008

    LY-3177833

    Cdc7 inhibitor.

    ≥99%
  • A5001

    Aminopterin

    Folic acid analog, derivative of pterin; dihydr...

    ≥98%
  • R2353

    RF-NH2

    RF-amide peptide; potential GPR147 agonist, pot...

    ≥95%
  • T9945

    Tylosin Tartrate

    Macrolide; peptidyl transferase inhibitor, prot...

    ≥90%
  • B011460

    Baloxavir Marboxil

    Cap-dependent endonuclease inhibitor  
    ≥ 99%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only